Gary Patou, Chief Medical Officer at Pacira Pharmaceuticals, Inc. (PCRX), sold 29,700 shares at $87.58 ($2.6M) on 2014-07-14, disclosed to the SEC on 2014-07-15.
Scheduled sale ($2.6M) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $86.91 | 27,593 | $2.4M | 92.9% |
| 2 | $87.58 | 2,107 | $185K | 7.1% |
| Total | $86.96 avg | 29,700 | $2.6M | 100% |
| Filing → |
| XENE | SELL | 2023-12-15 | $624K | — | Filing → |
| XENE | SELL | 2023-12-15 | $1.0M | — | Filing → |
| XENE | SELL | 2022-11-28 | $276K | — | Filing → |